Protocol for the EARCO Registry: a pan-European observational study in patients with α1-antitrypsin deficiency

Protocol for the EARCO Registry: a pan-European observational study in patients with α1-antitrypsin deficiency

Rationale and objectives Alpha-1 antitrypsin deficiency (AATD) is a genetic condition that leads to an increased risk of emphysema and liver disease. Despite extensive investigation, there remain unanswered questions concerning the natural history, pathophysiology, genetics and the prognosis of the...

Full description

Bibliographic Details
Main Authors:	Timm Greulich, Alan Altraja, Miriam Barrecheguren, Robert Bals, Jan Chlumsky, Joanna Chorostowska-Wynimko, Christian Clarenbach, Luciano Corda, Angelo Guido Corsico, Ilaria Ferrarotti, Cristina Esquinas, Caroline Gouder, Ana Hećimović, Aleksandra Ilic, Yavor Ivanov, Sabina Janciauskiene, Wim Janssens, Malcolm Kohler, Alvils Krams, Beatriz Lara, Ravi Mahadeva, Gerry McElvaney, Jean-François Mornex, Karen O'Hara, David Parr, Eava Piitulainen, Karin Schmid-Scherzer, Niels Seersholm, Robert A. Stockley, Jan Stolk, Maria Sucena, Hanan Tanash, Alice Turner, Ruxandra Ulmeanu, Marion Wilkens, Arzu Yorgancioğlu, Ana Zaharie, Marc Miravitlles
Format:	Article
Language:	English
Published:	European Respiratory Society 2020-03-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/6/1/00181-2019.full

Similar Items

Research priorities in α1-antitrypsin deficiency: results of a patients' and healthcare providers' international survey from the EARCO Clinical Research Collaboration
by: Miriam Barrecheguren, et al.
Published: (2020-12-01)

Assessment and monitoring of lung disease in patients with severe alpha 1 antitrypsin deficiency: a european delphi consensus of the EARCO group
by: Marc Miravitlles, et al.
Published: (2024-08-01)

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
by: Marc Miravitlles, et al.
Published: (2022-12-01)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)

Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
by: Marc Miravitlles, et al.
Published: (2023-02-01)

Advancing the understanding and treatment of lung pathologies associated with alpha 1 antitrypsin deficiency
by: Alice M. Turner, et al.
Published: (2025-02-01)

European Alpha-1 Research Collaboration (EARCO) in Portugal: The Future Is Happening
by: Maria Sucena, et al.
Published: (2024-11-01)

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
by: Chorostowska-Wynimko J, et al.
Published: (2020-02-01)

Implementation of European Alpha-1 Research Collaboration (EARCO) in Portugal: the future starts now
by: M. Sucena, et al.
Published: (2020-07-01)

Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project
by: Teresa Martín, et al.
Published: (2024-06-01)

Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01)

Diagnosis and management of α1-antitrypsin deficiency in Europe: an expert survey
by: Ildikó Horváth, et al.
Published: (2019-03-01)

Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group
by: Greulich T, et al.
Published: (2022-01-01)

Targeted screening programmes in COPD: how to identify individuals with α1-antitrypsin deficiency
by: Joanna Chorostowska-Wynimko
Published: (2015-03-01)

Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
by: María Torres-Durán, et al.
Published: (2022-09-01)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
by: Robert A. Stockley, et al.
Published: (2023-08-01)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
by: Sabina Janciauskiene, et al.
Published: (2018-04-01)

Alpha1-antitrypsin deficiency – misconceptions about an important clinical problem
by: Paweł Jan Kuca, et al.
Published: (2015-10-01)

Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer
by: Joanna Moes-Sosnowska, et al.
Published: (2022-03-01)

PAI-1 Level Differences in Malignant Plural Effusion, Parapneumonic Pleuritis, and Cardiac Hydrothorax
by: Dace Zentina, et al.
Published: (2019-09-01)

Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm
by: Noel G. McElvaney
Published: (2015-03-01)

Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43–45 years
by: Mostafavi B, et al.
Published: (2019-02-01)

Weaving a Personal Web: Using online technologies to create customized, connected, and dynamic learning environments
by: Jessica McElvaney, et al.
Published: (2010-05-01)

Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
by: Hiller AM, et al.
Published: (2019-05-01)

Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
by: Tanash HA, et al.
Published: (2016-07-01)

Plasma levels of α1-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients
by: Friedemann R. Börner, et al.
Published: (2023-12-01)

Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients
by: Janciauskiene S, et al.
Published: (2020-11-01)

How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?
by: Ilaria Ferrarotti, et al.
Published: (2015-01-01)

Sex differences in airway disease: estrogen and airway surface liquid dynamics
by: Brian J. Harvey, et al.
Published: (2024-07-01)

Circulating monocytes from healthy individuals and COPD patients
by: Piitulainen Eeva, et al.
Published: (2003-09-01)

Signs of Hyperinflation and Ventilation Heterogeneity in Individuals With Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
by: Schramm GR, et al.
Published: (2025-03-01)

Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
by: Karen McQuillan, et al.
Published: (2020-07-01)

Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls
by: Szpechcinski A, et al.
Published: (2009-12-01)

Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
by: Schramm GR, et al.
Published: (2021-12-01)

Impact of the EuroPsy <subtitle>A European Benchmark for Psychology Education and Training</subtitle>
by: Rosaleen McElvaney, et al.
Published: (2025-01-01)

Adolescents’ experiences of psychotherapy following child sexual abuse
by: Rosaleen McElvaney, et al.
Published: (2023-07-01)

The efficacy of internet-delivered treatment for generalized anxiety disorder: A systematic review and meta-analysis
by: Derek Richards, et al.
Published: (2015-09-01)

Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients.
by: Francesco Palmas, et al.
Published: (2021-01-01)

Survival in severe alpha-1-antitrypsin deficiency (PiZZ)
by: Nilsson Jan-Åke, et al.
Published: (2010-04-01)

Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency
by: Mostafavi B, et al.
Published: (2018-11-01)